Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NovoCure Ltd | Chief Science Officer | Stock Options (Right to buy) | 78.2K | $1.27M | $16.30 | Feb 27, 2024 | Direct |
NovoCure Ltd | Chief Science Officer | Ordinary Shares | 69.8K | $1.14M | $16.30 | Feb 27, 2024 | Direct |
NovoCure Ltd | Chief Science Officer | Restricted Share Units | 353 | Jul 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVCR | NovoCure Ltd | Feb 27, 2024 | 2 | $2.11M | 4 | Feb 29, 2024 | Chief Science Officer |
NVCR | NovoCure Ltd | Jul 26, 2023 | 0 | $0 | 3 | Dec 20, 2023 | Chief Science Officer |